Melatonin inhibits ESCC tumor growth by mitigating the HDAC7/β-catenin/c-Myc positive feedback loop and suppressing the USP10-maintained HDAC7 protein stability

Zhi-Qiang Ma; Ying-Tong Feng; Kai Guo; Dong Liu; Chang-Jian Shao; Ming-Hong Pan; Yi-Meng Zhang; Yu-Xi Zhang; Di Lu; Di Huang; Fan Zhang; Jin-Liang Wang; Bo Yang; Jing Han; Xiao-Long Yan; Yi Hu

doi:10.1186/s40779-022-00412-0

Your Location：

Home >

Browse articles >

Melatonin inhibits ESCC tumor growth by mitigating the HDAC7/β-catenin/c-Myc positive feedback loop and suppressing the USP10-maintained HDAC7 protein stability

RESEARCH | Updated：2023-05-10

- Melatonin inhibits ESCC tumor growth by mitigating the HDAC7/β-catenin/c-Myc positive feedback loop and suppressing the USP10-maintained HDAC7 protein stability
- Melatonin inhibits ESCC tumor growth by mitigating the HDAC7/β-catenin/c-Myc positive feedback loop and suppressing the USP10-maintained HDAC7 protein stability
- Military Medical Research 2023年10卷第2期页码：207-226
- Affiliations：
  
  1.Department of Medical Oncology, Senior Department of Oncology, the Fifth Medical Center, Chinese PLA General Hospital, Beijing 100853, China
  2.Department of Thoracic Surgery, Tangdu Hospital, the Fourth Military Medical University, Xi’an 710038, China
  3.Department of Cardiothoracic Surgery, the 71th Group Army Hospital of PLA, the Affiliated Huaihai Hospital of Xuzhou Medical University, Xuzhou 221004, Jiangsu, China
  4.Department of Thoracic Surgery, Shaanxi Provincial People's Hospital, the Third Affiliated Hospital of Xi’an Jiaotong University, Xi’an 710068, China
  5.State Key Laboratory of Cardiovascular Disease, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing 100037, China
  6.Department of Ophthalmology, Tangdu Hospital, the Fourth Military Medical University, Xi’an 710038, China
  7.Department of Cardiovascular Surgery, Xijing Hospital, the Fourth Military Medical University, Xi’an 710032, China
- Author bio：
  
  * hanjing@fmmu.edu.cn;
  yanxiaolong@fmmu.edu.cn;
  huyi301zlxb@sina.com
- Funds：
  
  the National Natural Science Foundation of China(82103508;81871866;82173252;81672996);the Natural Science Foundation of Shaanxi Province(2022JQ-862)
- DOI：10.1186/s40779-022-00412-0
  中图分类号：
- 纸质出版：2023-04
- Accepted：
Scan QR Code
Melatonin inhibits ESCC tumor growth by mitigating the HDAC7/β-catenin/c-Myc positive feedback loop and suppressing the USP10-maintained HDAC7 protein stability[J]. Military Medical Research, 2023,10(2):207-226.

Cite this article as: Ma ZQ, Feng YT, Guo K, Liu D, Shao CJ, Pan MH, et al. Melatonin inhibits ESCC tumor growth by mitigating the HDAC7/β-catenin/c-Myc positive feedback loop and suppressing the USP10-maintained HDAC7 protein stability. Mil Med Res. 2022;9(1):54.
Melatonin inhibits ESCC tumor growth by mitigating the HDAC7/β-catenin/c-Myc positive feedback loop and suppressing the USP10-maintained HDAC7 protein stability[J]. Military Medical Research, 2023,10(2):207-226. DOI： 10.1186/s40779-022-00412-0.

Cite this article as: Ma ZQ, Feng YT, Guo K, Liu D, Shao CJ, Pan MH, et al. Melatonin inhibits ESCC tumor growth by mitigating the HDAC7/β-catenin/c-Myc positive feedback loop and suppressing the USP10-maintained HDAC7 protein stability. Mil Med Res. 2022;9(1):54. DOI： 10.1186/s40779-022-00412-0.

摘要

Abstract

Background:

Melatonin

a natural hormone secreted by the pineal gland

has been reported to exhibit antitumor properties through diverse mechanisms of action. However

the oncostatic function of melatonin on esophageal squamous cell carcinoma (ESCC) remains elusive. This study was conducted to investigate the potential effect and underlying molecular mechanism of melatonin as single anticancer agent against ESCC cells.

Methods:

ESCC cell lines treated with or without melatonin were used in this study.

In vitro

colony formation and 5-Ethynyl-2'-deoxyuridine (EdU) incorporation assays

and nude mice tumor xenograft model were used to confirm the proliferative capacities of ESCC cells. RNA-seq

qPCR

Western blotting

recombinant lentivirus-mediated target gene overexpression or knockdown

plasmids transfection and co-IP were applied to investigate the underlying molecular mechanism by which melatonin inhibited ESCC cell growth. IHC staining on ESCC tissue microarray and further survival analyses were performed to explore the relationship between target genes’ expression and prognosis of ESCC.

Results:

Melatonin treatment dose-dependently inhibited the proliferative ability and the expression of histone deacetylase 7 (HDAC7)

c-Myc and ubiquitin-specific peptidase 10 (USP10) in ESCC cells (

0.05). The expressions of HDAC7

c-Myc and USP10 in tumors were significantly higher than the paired normal tissues from 148 ESCC patients (

0.001). Then

the Kaplan-Meier survival analysis suggested that ESCC patients with high HDAC7

c-Myc or USP10 levels predicted worse overall survival (log-rank

0.001). Co-IP and Western blotting further revealed that HDAC7 physically deacetylated and activated β-catenin thus promoting downstream target c-Myc gene transcription. Notably

our mechanistic study validated that HDAC7/β-catenin/c-Myc could form the positive feedback loop to enhance ESCC cell growth

and USP10 could deubiquitinate and stabilize HDAC7 protein in the ESCC cells. Additionally

we verified that inhibition of the HDAC7/β-catenin/c-Myc axis and USP10/HDAC7 pathway mediated the anti-proliferative action of melatonin on ESCC cells.

Conclusions:

Our findings elucidate that melatonin mitigates the HDAC7/β-catenin/c-Myc positive feedback loop and inhibits the USP10-maintained HDAC7 protein stability thus suppressing ESCC cell growth

and provides the reference for identifying biomarkers and therapeutic targets for ESCC.

关键词

Keywords

references

Ma Z , Liu D , Di S , Zhang Z , Li W , Zhang J , et al . Histone deacetylase 9 downregulation decreases tumor growth and promotes apoptosis in non-small cell lung cancer after melatonin treatment . J Pineal Res. 2019 ; 67 ( 2 ): e12587 .

Ma Z , Xu L , Liu D , Zhang X , Di S , Li W , et al . Utilizing melatonin to alleviate side effects of chemotherapy: a potentially good partner for treating cancer with ageing . Oxid Med Cell Longev. 2020 ; 2020 : 6841581 .

Andrade C , Srihari BS , Reddy KP , Chandramma L . Melatonin in medically ill patients with insomnia: a double-blind, placebo-controlled study . J Clin Psychiatry. 2001 ; 62 ( 1 ): 41 – 5 .

Comperatore CA , Lieberman HR , Kirby AW , Adams B , Crowley JS . Melatonin efficacy in aviation missions requiring rapid deployment and night operations . Aviat Space Environ Med. 1996 ; 67 ( 6 ): 520 – 4 .

Pinato DJ , Stebbing J . Melatonin: resetting the clock of cancer progression? Lancet Oncol. 2016 ; 17 ( 1 ): 23 – 4 .

Lang L , Xiong Y , Prieto-Dominguez N , Loveless R , Jensen C , Shay C , et al . FGF19/FGFR4 signaling axis confines and switches the role of melatonin in head and neck cancer metastasis . J Exp Clin Cancer Res. 2021 ; 40 ( 1 ): 93 .

Su SC , Hsieh MJ , Yang WE , Chung WH , Reiter RJ , Yang SF . Cancer metastasis: Mechanisms of inhibition by melatonin . J Pineal Res. 2017 ; 62 ( 1 ): e12370 .

Kong X , Gao R , Wang Z , Wang X , Fang Y , Gao J , et al . Melatonin: a potential therapeutic option for breast cancer . Trends Endocrinol Metab. 2020 ; 31 ( 11 ): 859 – 71 .

Li M , Hao B , Zhang M , Reiter RJ , Lin S , Zheng T , et al . Melatonin enhances radiofrequency-induced NK antitumor immunity, causing cancer metabolism reprogramming and inhibition of multiple pulmonary tumor development . Signal Transduct Target Ther. 2021 ; 6 ( 1 ): 330 .

Reiter RJ , Sharma R , Ma Q , Rorsales-Corral S , de Almeida Chuffa LG . Melatonin inhibits Warburg-dependent cancer by redirecting glucose oxidation to the mitochondria: a mechanistic hypothesis . Cell Mol Life Sci. 2020 ; 77 ( 13 ): 2527 – 42 .

Tian T , Li J , Li Y , Lu YX , Tang YL , Wang H , et al . Melatonin enhances sorafenib-induced cytotoxicity in FLT3-ITD acute myeloid leukemia cells by redox modification . Theranostics. 2019 ; 9 ( 13 ): 3768 – 79 .

Wei W , Zeng H , Zheng R , Zhang S , An L , Chen R , et al . Cancer registration in China and its role in cancer prevention and control . Lancet Oncol. 2020 ; 21 ( 7 ): e342 – 9 .

Tang H , Jiang L , Zhu C , Liu R , Wu Y , Yan Q , et al . Loss of cell adhesion molecule L1 like promotes tumor growth and metastasis in esophageal squamous cell carcinoma . Oncogene. 2019 ; 38 ( 17 ): 3119 – 33 .

Li X , Song S , Liu Y , Ko SH , Kao HY . Phosphorylation of the histone deacetylase 7 modulates its stability and association with 14-3-3 proteins . J Biol Chem. 2004 ; 279 ( 33 ): 34201 – 8 .

Lei Y , Liu L , Zhang S , Guo S , Li X , Wang J , et al . Hdac7 promotes lung tumorigenesis by inhibiting Stat3 activation . Mol Cancer. 2017 ; 16 ( 1 ): 170 .

Cutano V , Di Giorgio E , Minisini M , Picco R , Dalla E , Brancolini C . HDAC7-mediated control of tumour microenvironment maintains proliferative and stemness competence of human mammary epithelial cells . Mol Oncol. 2019 ; 13 ( 8 ): 1651 – 68 .

Yu X , Wang M , Wu J , Han Q , Zhang X . ZNF326 promotes malignant phenotype of glioma by up-regulating HDAC7 expression and activating Wnt pathway . J Exp Clin Cancer Res. 2019 ; 38 ( 1 ): 40 .

Zhu C , Chen Q , Xie Z , Ai J , Tong L , Ding J , et al . The role of histone deacetylase 7 (HDAC7) in cancer cell proliferation: regulation on c-Myc . J Mol Med (Berl). 2011 ; 89 ( 3 ): 279 – 89 .

Yu Y , Cao F , Yu X , Zhou P , Di Q , Lei J , et al . The expression of HDAC7 in cancerous gastric tissues is positively associated with distant metastasis and poor patient prognosis . Clin Transl Oncol. 2017 ; 19 ( 8 ): 1045 – 54 .

Bugter JM , Fenderico N , Maurice MM . Mutations and mechanisms of WNT pathway tumour suppressors in cancer . Nat Rev Cancer. 2021 ; 21 ( 1 ): 5 – 21 .

Li Y , Zhang X , Polakiewicz RD , Yao TP , Comb MJ . HDAC6 is required for epidermal growth factor-induced beta-catenin nuclear localization . J Biol Chem. 2008 ; 283 ( 19 ): 12686 – 90 .

Zhu H , Yan F , Yuan T , Qian M , Zhou T , Dai X , et al . USP10 promotes proliferation of hepatocellular carcinoma by deubiquitinating and stabilizing YAP/TAZ . Cancer Res. 2020 ; 80 ( 11 ): 2204 – 16 .

Guturi KKN , Bohgaki M , Bohgaki T , Srikumar T , Ng D , Kumareswaran R , et al . RNF168 and USP10 regulate topoisomerase IIα function via opposing effects on its ubiquitylation . Nat Commun. 2016 ; 7 : 12638 .

Hu C , Zhang M , Moses N , Hu CL , Polin L , Chen W , et al . The USP10-HDAC6 axis confers cisplatin resistance in non-small cell lung cancer lacking wild-type p53 . Cell Death Dis. 2020 ; 11 ( 5 ): 328 .

Weisberg EL , Schauer NJ , Yang J , Lamberto I , Doherty L , Bhatt S , et al . Inhibition of USP10 induces degradation of oncogenic FLT3 . Nat Chem Biol. 2017 ; 13 ( 12 ): 1207 – 15 .

Yang J , Meng C , Weisberg E , Case A , Lamberto I , Magin RS , et al . Inhibition of the deubiquitinase USP10 induces degradation of SYK . Br J Cancer. 2020 ; 122 ( 8 ): 1175 – 84 .

Cai B , Ma W , Bi C , Yang F , Zhang L , Han Z , et al . Long noncoding RNA H19 mediates melatonin inhibition of premature senescence of c-kit(+) cardiac progenitor cells by promoting miR-675 . J Pineal Res. 2016 ; 61 ( 1 ): 82 – 95 .

Ma Z , Liu D , Li W , Di S , Zhang Z , Zhang J , et al . STYK1 promotes tumor growth and metastasis by reducing SPINT2/HAI-2 expression in nonsmall cell lung cancer . Cell Death Dis. 2019 ; 10 ( 6 ): 435 .

Kress TR , Sabò A , Amati B . MYC: connecting selective transcriptional control to global RNA production . Nat Rev Cancer. 2015 ; 15 ( 10 ): 593 – 607 .

Wagner T , Brand P , Heinzel T , Krämer OH . Histone deacetylase 2 controls p53 and is a critical factor in tumorigenesis . Biochim Biophys Acta. 2014 ; 1846 ( 2 ): 524 – 38 .

Li Y , Seto E . HDACs and HDAC inhibitors in cancer development and therapy . Cold Spring Harb Perspect Med. 2016 ; 6 ( 10 ): a026831 .

Hsu A , Duan Q , McMahon S , Huang Y , Wood SA , Gray NS , et al . Salt-inducible kinase 1 maintains HDAC7 stability to promote pathologic cardiac remodeling . J Clin Invest. 2020 ; 130 ( 6 ): 2966 – 77 .

Li QG , Xiao T , Zhu W , Yu ZZ , Huang XP , Yi H , et al . HDAC7 promotes the oncogenicity of nasopharyngeal carcinoma cells by miR-4465-EphA2 signaling axis . Cell Death Dis. 2020 ; 11 ( 5 ): 322 .

Lee H , Lee HJ , Jung JH , Shin EA , Kim SH . Melatonin disturbs SUMOylationmediated crosstalk between c-Myc and nestin via MT1 activation and promotes the sensitivity of paclitaxel in brain cancer stem cells . J Pineal Res. 2018 ; 65 ( 2 ): e12496 .

Lim R , Sugino T , Nolte H , Andrade J , Zimmermann B , Shi C , et al . Deubiquitinase USP10 regulates Notch signaling in the endothelium . Science. 2019 ; 364 ( 6436 ): 188 – 93 .

Yuan J , Luo K , Zhang L , Cheville JC , Lou Z . USP10 regulates p53 localization and stability by deubiquitinating p53 . Cell. 2010 ; 140 ( 3 ): 384 – 96 .

Wang X , Xia S , Li H , Wang X , Li C , Chao Y , et al . The deubiquitinase USP10 regulates KLF4 stability and suppresses lung tumorigenesis . Cell Death Differ. 2020 ; 27 ( 6 ): 1747 – 64 .

Zhou L , Zhang C , Yang X , Liu L , Hu J , Hou Y , et al . Melatonin inhibits lipid accumulation to repress prostate cancer progression by mediating the epigenetic modification of CES1 . Clin Transl Med. 2021 ; 11 ( 6 ): e449 .

Li M , Wu C , Muhammad JS , Yan D , Tsuneyama K , Hatta H , et al . Melatonin sensitises shikonin-induced cancer cell death mediated by oxidative stress via inhibition of the SIRT3/SOD2-AKT pathway . Redox Biol. 2020 ; 36 : 101632 .

Liu Z , Sang X , Wang M , Liu Y , Liu J , Wang X , et al . Melatonin potentiates the cytotoxic effect of Neratinib in HER2(+) breast cancer through promoting endocytosis and lysosomal degradation of HER2 . Oncogene. 2021 ; 40 ( 44 ): 6273 – 83 .

浏览量

Downloads

CSCD

文章被引用时，请邮件提醒。

Submit

工具集

关联资源

β-catenin initiates peritoneal fibrosis by triggering mitochondrial fission-mediated mesothelial cell senescence fate transition

Melatonin attenuates radiation-induced cortical bone-derived stem cells injury and enhances bone repair in postradiation femoral defect model

长大货物列车空气管系3维充气模型的数值仿真

架悬机车驱动装置悬挂参数及结构的研究

渝怀线武隆隧道岩溶涌水量计算新方法